Spiral Microchannel Cell Isolation via Dean Migration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional macroscale methods for separating cells, such as physical filtration and density gradient centrifugation, are labor-intensive, prone to cell loss, and can introduce mechanical stress, while microfluidics systems face limitations in processing throughput due to sample dilution and slow flow rates, making them unsuitable for clinical blood samples.
Innovation Solution
A microfluidic device with curvilinear channels that utilize Dean migration and inertial focusing to isolate circulating tumor cells (CTCs) from other cells by creating a predetermined force ratio, allowing for high flow rates and efficient separation without chemical modification of the sample, using spiral microchannels with specific dimensions to equilibrate cells based on size and collect CTCs at a higher throughput.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional macroscale methods (physical filtration, density gradient centrifugation) are used for cell separation, then separation can be achieved, but the process becomes labor-intensive, requires multi-step sample preparations, and causes cell loss
Solution Approach 1:
The patent replaces conventional macroscale mechanical separation methods (filtration, centrifugation) with a microfluidic system that uses controlled fluid dynamics at the microscale. The microfluidic device employs laminar flow and hydrodynamic forces to achieve cell separation in a single continuous step, eliminating the need for multiple mechanical preparation steps while maintaining separation effectiveness.
Solution Approach 2:
The invention transitions from macroscale two-dimensional separation (filtration membranes, centrifugal gradients) to microscale three-dimensional hydrodynamic control. The microfluidic channel creates complex flow patterns in three dimensions that enable separation based on cell size and deformability without requiring multiple sequential steps.
2Measurement precision
If membrane filtration methods are used for cell separation, then target cells can be filtered out, but the method is easily susceptible to clogging and requires frequent cleaning
Solution Approach 1:
The patent replaces membrane filtration with a microfluidic hydrodynamic separation system that uses flow dynamics rather than physical barriers. Cells are separated based on their response to hydrodynamic forces in the microchannel, eliminating the membrane that would clog while maintaining separation efficiency through continuous flow.
Solution Approach 2:
The microfluidic system uses the sample's own flow properties and cell characteristics (size, deformability) to achieve separation without requiring external intervention for cleaning or maintenance. The continuous laminar flow regime prevents particle accumulation that would cause clogging in filtration systems.
3Reliability
If microfluidics systems are used for blood sample processing, then better control of cellular microenvironment can be achieved, but processing throughput is low due to sample dilution and slow flow rates
Solution Approach 1:
The patent optimizes key microfluidic parameters including channel dimensions (width, height, curvature radius), flow rates, and cell concentration to achieve both high throughput and maintained microenvironment control. By carefully selecting the channel curvature radius and flow velocity, the system processes clinical blood sample volumes rapidly while maintaining laminar flow and physiological relevance.
Solution Approach 2:
The system employs dynamic flow control with adjustable flow rates that can be optimized for different sample volumes and cell types. The microfluidic device transitions from static filtration to dynamic hydrodynamic separation, allowing rapid processing of milliliter-scale blood samples while maintaining cellular integrity through controlled shear stress.
4Measurement precision
If filtration and centrifugation techniques are used for cell separation, then cell isolation can be achieved, but mechanical stress-induced changes in original phenotype of target cells occur
Solution Approach 1:
The patent replaces high-stress mechanical methods (filtration through membranes, high-speed centrifugation) with gentle microfluidic hydrodynamic separation. The microchannel dimensions and flow rates are designed to create mild shear stresses that separate cells based on size and deformability without causing mechanical damage or phenotype changes.
Solution Approach 2:
The system controls flow velocity and channel geometry parameters to maintain shear stress below thresholds that would induce cellular stress responses. By optimizing the channel curvature radius and flow rate, the patent achieves effective separation while keeping mechanical forces at levels that preserve cell viability and original phenotype.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device enables continuous high-throughput processing of clinical samples, minimizing cell loss and maintaining cell viability, with the ability to process 1 mL of whole blood in under 10 minutes and achieve 90% CTC recovery, while reducing sample preparation steps and analysis time.
Implementation Method 1
at least one curvilinear channel through which the sample is caused to undergo migration along at least a partial Dean vortex to isolate the circulating tumor cells from the other cells
Implementation Method 2
The curvilinear channel is configured to provide a predetermined Force ratio greater than or equal to 2 based on a desired threshold cell size of 15-20 μm of the circulating tumor cells, the predetermined Force ratio being defined as a ratio of inertial lift force (F L ) to Dean drag force (F D )
Data Source
Figure 1A~2
Figure 3~4B
Figure 5(a)~5(d)
AI summary
A microfluidic device is disclosed. The device comprises at least one inlet for receiving circulating tumor cells and other cells in a sample; at least one curvilinear and/or spiral channel through which the sample is caused to undergo partial or complete Dean cycles to isolate the circulating tumor cells from the other cells; and at least one outlet configured to communicate with the channel for providing the isolated circulating tumor cells. The channel is configured to provide a predetermined Force ratio based on a desired threshold cell size of the circulating tumor cells. A corresponding method of manufacturing of the device, and a related diagnostic system are also disclosed.